Genelink Stock

Genelink Equity

The The Equity of Genelink (GNLKQ) as of Aug 9, 2026 is -2.66 M USD.

Equity

-2.66 MUSD

Last updated:

In 2026, Genelink's equity was -2.66 M USD, a % increase from the - USD equity in the previous year.

Access this data via the Eulerpool API

Genelink Stock analysis

What does Genelink do? Genelink Inc is a company specializing in the development and marketing of dietary supplements and health products. It was founded in 1996 by Dr. Alan Darmitzel and is headquartered in Salt Lake City, Utah, USA. The company's business model is based on personalizing dietary supplements and health promotion products. Genelink uses DNA analysis to determine the specific needs of each customer and manufactures customized dietary supplements and health products based on these results. Genelink offers a wide range of health products tailored to the needs of each individual. The company has various divisions that offer products such as dietary supplements, skincare products, and weight management products. Genelink supplies a variety of dietary supplements tailored to the needs of each individual customer. The supplements contain ingredients tailored to each customer's genetic profile. For example, a customer at high risk for heart disease may be offered a dietary supplement with ingredients that can reduce the risk of heart disease. Genelink also offers a range of skincare products tailored to the individual needs of each customer. The skincare products contain ingredients tailored to each customer's specific needs, such as skin type and age. The company also offers specialized weight management products tailored to the individual needs of each customer. The products contain ingredients that facilitate weight management and can reduce the risk of weight gain. In summary, Genelink Inc is a company that offers personalized health solutions. Based on the results of DNA analysis, the company manufactures customized dietary supplements, skincare products, and weight management products. Genelink's products and services are designed to meet the individual needs of each customer and provide a personalized approach to health promotion. Genelink is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Genelink's Equity

Genelink's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Genelink's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Genelink's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Genelink's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Genelink’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Genelink stock

The Equity of Genelink is -2.66 M USD in 2026.

On Eulerpool you can find the complete historical development of The Equity Genelink since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Genelink historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Genelink

All Key Metrics — Genelink